Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Liabilities and Shareholders Equity: 2011-2024

Historic Liabilities and Shareholders Equity for Mimedx Group (MDXG) over the last 14 years, with Dec 2024 value amounting to $263.9 million.

  • Mimedx Group's Liabilities and Shareholders Equity rose 30.79% to $319.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 22.43%. This contributed to the annual value of $263.9 million for FY2024, which is 10.40% up from last year.
  • According to the latest figures from FY2024, Mimedx Group's Liabilities and Shareholders Equity is $263.9 million, which was up 10.40% from $239.0 million recorded in FY2023.
  • Over the past 5 years, Mimedx Group's Liabilities and Shareholders Equity peaked at $263.9 million during FY2024, and registered a low of $171.4 million during FY2022.
  • In the last 3 years, Mimedx Group's Liabilities and Shareholders Equity had a median value of $239.0 million in 2023 and averaged $224.8 million.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first declined by 8.78% in 2022, then skyrocketed by 39.44% in 2023.
  • Yearly analysis of 5 years shows Mimedx Group's Liabilities and Shareholders Equity stood at $202.0 million in 2020, then dropped by 6.98% to $187.9 million in 2021, then declined by 8.78% to $171.4 million in 2022, then spiked by 39.44% to $239.0 million in 2023, then rose by 10.40% to $263.9 million in 2024.